
Since 1899, Marquis Who’s Who in America has celebrated individuals and innovators ranked as the most accomplished in every significant field of endeavour. Among the 2026 honourees, the name of Prof. Henrietta Ngozi Ukwu stands out, not just because she is a Nigerian but because of the remarkable immensity and global impact of her contributions to healthcare. Her profile is distinguished by a career that has consistently influenced how critical medicines reach populations worldwide. From formulating regulatory frameworks to enabling access to therapies that have altered the course of major diseases, her work has touched millions of lives across continents, leaving an imprint that is both far-reaching and indelible.
An infectious diseases physician turned pharmaceutical executive, Ukwu has spent more than three decades working within the complex systems that govern drug development and approval. Over that period, she has led regulatory efforts that have culminated in more than 30 original product approvals worldwide. These include vaccines and therapies that have redefined treatment paradigms and expanded access to essential care across diverse populations.
Ukwu’s influence is perhaps most evident in her contributions to two defining health crises of recent history. At Merck, she played a pivotal role in advancing regulatory approval for Crixivan, a breakthrough HIV protease inhibitor that helped change HIV/AIDS from a terminal illness to a chronic, manageable condition. Years later, at Novavax, she again stood at the centre of a global emergency, guiding the regulatory strategy for a COVID-19 vaccine amid unprecedented scientific urgency and evolving regulatory expectations. In both instances, her work ensured that critical interventions moved efficiently through complex approval processes to reach patients worldwide.
Presently serving as executive vice president and chief regulatory officer at Novavax Inc., a biotechnology company headquartered in the United States, Ukwu continues to transform global health outcomes from a position of strategic influence. Her role involves not only overseeing regulatory and quality frameworks, but also fostering collaboration with international agencies to ensure that innovation is translated into safe, effective, and accessible treatments.
Laying the foundations
Prof. Ukwu was born and raised in Enugu State, Nigeria. A native of Amokwe, in the Udi Local Government Area, she attended Queen’s School, an elite all-girls school in Enugu, known for producing high-achieving women. She subsequently obtained her Bachelor of Medicine and Bachelor of Surgery from the University of Jos in 1982.
Soon after, she moved to the United States, where she completed an internal medicine internship at Meharry Medical College’s Hubbard Hospital in Nashville, followed by a residency at Baptist Hospital affiliated with the University of Tennessee. She later undertook a fellowship in infectious diseases at Vanderbilt University School of Medicine, completing her specialist training in 1991.
It was during this period that her interest in the pharmaceutical industry began to form. While clinical practice offered the opportunity to impact individual lives, she recognised that pharmaceutical medicine provided a platform for wider influence. “I believed the work we do has a broad and far-reaching impact on humanity,” she recalls. “This has borne out as true.”
Her decision to enter the pharmaceutical industry in 1992 would prove critical, setting the stage for a career defined by global reach and sustained impact.
Career excellence
Prior to her current role at Novavax, Ukwu held senior executive positions at Otsuka Pharmaceutical Companies, where she served as senior vice president and global head of regulatory affairs and global quality. In this capacity, she led efforts to ensure compliance excellence, inspection readiness, and effective engagement with global regulatory authorities.
Her earlier tenure at PPD as senior vice president and head of global regulatory affairs further strengthened her expertise in regulatory strategy across diverse product portfolios and geographical regions.
At Pfizer, where she served as vice president of global regulatory affairs from 2004 to 2010, she oversaw regulatory strategies spanning vaccines, biologics, and pharmaceuticals. Her work required navigating complex international frameworks while ensuring timely approvals for critical therapies.
However, it was at Merck, where she began her pharmaceutical career in 1992, that she laid the foundation for her lasting legacy. There, she led regulatory efforts for major products including Varivax, the chickenpox vaccine, and Crixivan, the HIV protease inhibitor. These early successes established her reputation as a leader capable of guiding high-impact therapies through demanding regulatory processes.
Across these roles, Ukwu has consistently demonstrated an ability to align scientific innovation with regulatory requirements, ensuring that promising therapies are translated into accessible treatments.
Thought leadership and mentorship
Beyond her executive roles, Prof. Ukwu has made significant contributions to the intellectual and professional development of regulatory science.
She is the author of the landmark textbook, Global Regulatory Systems: A Strategic Primer for Biopharmaceutical Product Development and Registration, which is widely regarded as the quintessential guidebook for professionals navigating global regulatory frameworks.
Her second book, ABCs of Leadership: Leadership Guiding Principles, demonstrates her commitment to cultivating effective leadership within and beyond the pharmaceutical industry. She has equally written numerous articles and spoken widely global regulatory systems, pharmaceutical development and health systems transformation.
Equally noteworthy is her role as a mentor. Over the years, she has guided numerous professionals who have gone on to occupy senior leadership positions within the industry. Her emphasis on developing others reflects a broader philosophy that leadership is most effective when it multiplies itself.
She has also contributed academically as a pioneer professor in Temple University’s Quality Assurance and Regulatory Affairs graduate programme, further extending her influence to the next generation of professionals.
Giving back to homeland
Despite her global career, Prof. Ukwu has maintained a strong connection to Nigeria. She has consistently sought opportunities to contribute to the development of the country’s healthcare system, offering insights through lectures, advisory roles, and public engagement. She was most recently the keynote speaker at the 29th Annual National Conference and Training Programme of the Association of Industrial Pharmacists of Nigeria (NAIP), held from 3 to 8 May, where she spoke on “Nigeria’s Pharmaceutical Industry as a Pillar of National Health, Wealth, and Security,”
Her commitment extends beyond professional contributions to tangible community development initiatives. She runs a monthly charity outreach programme dedicated to the poor and less privileged in her hometown and the environs. Through this initiative, she extends food, support, and encouragement to the underprivileged.
Also, in collaboration with her family, she has supported projects aimed at improving living conditions in her village, including the provision of a reliable water supply, road infrastructure, and solar lighting.
She has also expressed a desire to contribute more directly to Nigeria’s public health system in the future, bringing her extensive international experience to bear on local challenges.
Awards and recognitions
Prof. Ukwu’s illustrious career has been adorned with numerous prestigious awards and honours. In addition to her inclusion in Marquis Who’s Who in America (2026), she is a two-time recipient of the PharmaVoice 100 award, recognised first as an Inspirational Leader in 2011 and later as a Legacy Leader in 2023.
She was ranked in Top 100 Most Important Blacks in Technology in USA in 2006 and named Scientist of the Year by BEYA Stem Minorities in Research Science in 2010. She equally received the TOPRA award for inspirational leadership in 2012 and was named among the Top Blacks in Healthcare in the United States in 2019.
She is also a Fellow of both the American College of Physicians and the Regulatory Affairs Professionals Society, as well as being a pioneer professor of Temple University’s Quality Assurance/Regulatory Affairs graduate programme.

























































